Specific oxidative stress profile associated with partial striatal dopaminergic depletion by 6-hydroxydopamine as assessed by a novel multifunctional marker molecule (Q43108497)

From Wikidata

Jump to navigation Jump to search

scientific article published in June 2010

Language	Label	Description	Also known as
English	Specific oxidative stress profile associated with partial striatal dopaminergic depletion by 6-hydroxydopamine as assessed by a novel multifunctional marker molecule	scientific article published in June 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Specific oxidative stress profile associated with partial striatal dopaminergic depletion by 6-hydroxydopamine as assessed by a novel multifunctional marker molecule (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Y Aluf

1

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

J Vaya

2

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

S Khatib

3

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Y Loboda

4

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

S Kizhner

5

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

John P M Finberg

6

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

publication date

1 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Free Radical Research

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

44

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

635-644

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Mitochondrial dysfunction in neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Melatonin and Parkinson's disease

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

An exogenous marker: a novel approach for the characterization of oxidative stress.

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Exogenous N-linoleoyl tyrosine marker as a tool for the characterization of cellular oxidative stress in macrophages

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Cholesterol, linoleic acid or/and tyrosine yield different spectra of products when oxidized alone or in a mixture: studies in various oxidative systems

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Oxysterols, cholesterol homeostasis, and Alzheimer disease

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Characterization of dansylated glutathione, glutathione disulfide, cysteine and cystine by narrow bore liquid chromatography/electrospray ionization mass spectrometry.

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Selective distribution of oxysterols in atherosclerotic lesions and human plasma lipoproteins

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Capillary GC quantification of cholesterol oxidation products in plasma lipoproteins of fasted humans

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Oxidative stress and neurotoxicity

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Increased 8-OHdG levels in the urine, serum, and substantia nigra of hemiparkinsonian rats

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Time-course of brain oxidative damage caused by intrastriatal administration of 6-hydroxydopamine in a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Oxidative stress and dopamine depletion in an intrastriatal 6-hydroxydopamine model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Molecular basis of 6-hydroxydopamine-induced caspase activations due to increases in oxidative stress in the mouse striatum

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Parkinson's disease: a disorder due to nigral glutathione deficiency?

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Mechanisms compensating for dopamine loss in early Parkinson disease

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Neurochemical Compensation After Nigrostriatal Bundle Injury in an Animal Model of Preclinical Parkinsonism

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Presymptomatic compensation in Parkinson's disease is not dopamine-mediated

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in parkinson's disease

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Dopamine release and uptake rates both decrease in the partially denervated striatum in proportion to the loss of dopamine terminals

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Effects of alpha-phenyl-N-tert-butyl nitrone and N-acetylcysteine on hydroxyl radical formation and dopamine depletion in the rat striatum produced by d-amphetamine

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Circuits and circuit disorders of the basal ganglia

1 reference

https://api.crossref.org/works/10.3109%2F10715761003692529

21 January 2018

Identifiers

10.3109/10715761003692529

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43108497&oldid=1981163263"